Bottom line
How has USVAX performed?
As of Dec 31, 2025, USVAX returned +2.6% over the past year, +0.5% a year over five years, +1.9% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $12,100. Its five-year return beat 39% of core / intermediate bond funds we track. Its best quarter was +9.6% and its worst −5.6%.
Updated Dec 31, 2025
USVAX annual returns by year
| Year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| USVAX | +2.6% | +2.1% | +6.5% | −9.8% | +2.0% | +4.4% | +6.2% | +0.8% | +4.6% | +0.8% |
Source: Fund prospectus bar chart (risk/return summary)
Growth of $10,000 in USVAX
$10,000 invested at the start of 2016 would have been worth about $12,100 by the end of 2025, based on the fund's reported calendar-year returns.
| Year | Return | Value of $10,000 |
|---|---|---|
| 2025 | +2.6% | $12,082 |
| 2024 | +2.1% | $11,778 |
| 2023 | +6.5% | $11,541 |
| 2022 | −9.8% | $10,841 |
| 2021 | +2.0% | $12,015 |
| 2020 | +4.4% | $11,783 |
| 2019 | +6.2% | $11,284 |
| 2018 | +0.8% | $10,629 |
| 2017 | +4.6% | $10,543 |
| 2016 | +0.8% | $10,081 |
Trailing returns vs benchmark and category
| 1 yr | 5 yr | 10 yr | Since inception | |
|---|---|---|---|---|
| USVAX | +2.6% | +0.5% | +1.9% | — |
| Core / Intermediate Bond median | +7.2% | +1.4% | +3.0% | — |
Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com
Recent monthly returns
For the three months ending May 31, 2026, USVAX returned −2.02%, +1.83%, +0.47% (oldest to newest), per SEC Form N-PORT.
Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.